Antitauon -

Using antisense oligonucleotides (ASOs) or "intrabodies" to reduce tau levels within the cell.

Promoting the removal of pathological tau via microglia or through intracellular degradation pathways like the proteasome. Key Therapeutic Strategies antitauon

Vaccines that stimulate the patient's own immune system to produce anti-tau antibodies. , ACI-35 Intracellular Targeting Gosuranemab Active Immunotherapy

Administration of lab-made monoclonal antibodies (mAbs) to target specific tau epitopes. , Semorinemab , Gosuranemab Active Immunotherapy antitauon